Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

Visiongain new report: Global anti obesity drugs market forecast 2018-2028

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Wird geladen in …3
×

Hier ansehen

1 von 3 Anzeige

Visiongain new report: Global anti obesity drugs market forecast 2018-2028

Herunterladen, um offline zu lesen

Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase Inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs

Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase Inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs

Anzeige
Anzeige

Weitere Verwandte Inhalte

Diashows für Sie (20)

Ähnlich wie Visiongain new report: Global anti obesity drugs market forecast 2018-2028 (20)

Anzeige

Visiongain new report: Global anti obesity drugs market forecast 2018-2028

  1. 1. / Page 86visiongain.com/industries/pharma Global Anti-obesity Drugs Market Forecast 2018-2028: Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase Inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs cholecystokinin and peptide YY etc. have further strengthened the forecasted growth arte of this market. Table 4.13 Global Anti-obesity Other Drugs Market 2017-2028: Revenue ($m), AGR (%), CAGR (%) 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Others (Revenue, $m) 73 101 133 194 292 448 680 1,037 1,577 2,438 3,812 5,904 AGR (%) 34.5% 37.8% 32.0% 46.0% 50.7% 53.2% 52.0% 52.4% 52.0% 54.6% 56.4% 54.9% CAGR (%, 2017-22 & 2023-28) 43.7 53.4 CAGR (%, 2017- 27) 48.9 Source: Visiongain 2018 Figure 4.17 Global Anti-obesity Other Drugs Market 2017-2028: Revenue ($m), AGR (%) Source: Visiongain 2018 0% 10% 20% 30% 40% 50% 60% - 1,000 2,000 3,000 4,000 5,000 6,000 7,000 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 AGR,% Revenue,$m Year
  2. 2. / Page 134visiongain.com/industries/pharma Global Anti-obesity Drugs Market Forecast 2018-2028: Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase Inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs Table 5.9 Qysmia Sales Forecast 2017-2028: Revenue ($m), AGR (%), CAGR (%) 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Revenue, $m 86 93 115 142 179 225 292 386 515 690 927 1,249 AGR (%) 9.0% 23.1% 24.1% 25.5% 26.1% 29.5% 32.5% 33.3% 34.0% 34.3% 34.8% CAGR (%, 2017-22 & 2023-28) 21.4 33.8 CAGR (%, 2017-28) 27.6 Source: Visiongain 2018 Figure 5.17 Qysmia Sales Forecast 2017-2028: Revenue ($m), AGR (%) Source: Visiongain 2018 0% 5% 10% 15% 20% 25% 30% 35% 40% - 200 400 600 800 1,000 1,200 1,400 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 AGR,% Revenue,$m
  3. 3. / Page 200visiongain.com/industries/pharma Global Anti-obesity Drugs Market Forecast 2018-2028: Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase Inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs In the global market, market share of China, India, Brazil, and Russia are expected to be 7.7%, 5.8%, 2.9%, and 1.1%, respectively, by 2028. Amongst the BRIC countries, the market share of China, India, Brazil, and Russia are 43.8%, 33.3%, 16.8%, and 6.1%, respectively by 2028. Figure 6.33 BRIC Anti-obesity Drugs Market Forecast by Region: Global Market Share (%), 2028 Source: Visiongain 2018 Figure 6.34 BRIC Anti-obesity Drugs Market Forecast by Region: Market Share (%), 2017 Source: Visiongain 2018 US 51.4% EU5 13.6% Japan 3.6% RoW 13.9% China 7.7% India 5.8% Brazil 2.9% Russia 1.1% BRIC 8.3% 38.4% 32.5% 19.5% 9.6% China India Brazil Russia

×